Sean Mc Carthy
About Sean Mc Carthy
Title and Role at CytomX
Sean A. McCarthy is the Chief Executive Officer and Chairman of CytomX. He joined the company in 2010 as the Chief Business Officer and has served as the Chief Executive Officer since 2011. In 2019, he also took on the role of Chairman. Under his leadership, CytomX has focused on advancing the discovery and development of innovative oncological therapies.
Previous Experience in Biotechnology
Before joining CytomX, Sean A. McCarthy was a transactional partner at Pappas Ventures, where he was involved in investment and partnership transactions. He also headed business development and strategy at SGX Pharmaceuticals, which specialized in structure-based drug discovery for oncology. Earlier in his career, McCarthy held various research and development roles at Millennium Pharmaceuticals, further contributing to his expertise in the biotechnology field.
Educational Background
Sean A. McCarthy holds a B.S. degree in biochemistry and pharmacology from King's College, University of London. He also earned a DPhil in cancer biology from St. John's College, University of Oxford. Additionally, McCarthy received an M.B.A. from the Rady School of Management at the University of California, San Diego, enriching his scientific knowledge with business acumen.
Contributions to Scientific Research
Sean A. McCarthy is an author on multiple peer-reviewed scientific publications and holds issued patents. His contributions to scientific research, particularly in the field of oncology, are well-documented and have had a significant impact on the development of new therapies.
Board Memberships and Industry Involvement
In addition to his roles at CytomX, Sean A. McCarthy is a member of the board of directors of Oncoresponse, Inc. He is also a member of the board of directors and the executive committee of California Life Sciences. These roles suggest his active involvement in the broader life sciences and biotechnology communities.